Lifecore Biomedical Inc expected to post a loss of 23 cents a share - Earnings Preview

Lifecore Biomedical

22/12/2023 13:32

* Lifecore Biomedical Inc  LFCR.OQ   LFCR.O  is expected
to show a
fall in quarterly revenue when it reports  results on December
26 (estimated) for the period ending May 31 2023
    * The Chaska Minnesota-based  company is expected to report
a
43.4% decrease in revenue to $24.545 million from $43.36 million
a year ago, according to the mean estimate from 2 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Lifecore Biomedical Inc
is for
a loss of 23 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lifecore
Biomedical Inc is $9.00​, above​ its last closing price
of $6.05. ​​​

The company's guidance on August 31 2023 for the period ended
August 31 was for Earnings before Interest, Taxes, Depreciation
and Amortization of of USD0.
This summary was machine generated December 22 at 13:32 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)